Amgen Announces New Data Being Presented At ASH 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Subgroup Analysis News
Page 7 - Subgroup Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Subgroup Analysis. Real-time updates on events, politics, business and more.
Neurelis Announces 16 Poster Presentations at the Annual Meeting of the American Epilepsy Society
/PRNewswire/ -- Neurelis, Inc. will present a collection of 16 posters describing safety, tolerability and effectiveness results observed in trials evaluating...
United States Enrique Carrazana Adrianl Rabinowicz Mark Leonard School Setting American Epilepsy Society
Source: prnewswire.com
Neurelis Announces 16 Poster Presentations at the Annual Meeting of the American Epilepsy Society
/PRNewswire/ -- Neurelis, Inc. will present a collection of 16 posters describing safety, tolerability and effectiveness results observed in trials evaluating...
United States Enrique Carrazana Adrianl Rabinowicz Mark Leonard School Setting American Epilepsy Society
Source: prnewswire.com
Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Present Data Showcasing Clinical Advances Across Hematology/Oncology at ASH 2021 Annual Meeting
Sixteen new abstracts to be presented, including the first presentation of data from the Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) Phase 2/3 study that supported U.S. FDA
Source: finanznachrichten.de
Jazz Pharmaceuticals to Present Data Showcasing Clinical Advances Across Hematology/Oncology at ASH 2021 Annual Meeting
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 16 new data abstracts from across its hematology/oncology development program will...
Source: prnewswire.com
Jazz Pharmaceuticals to Present Data Showcasing Clinical Advances Across Hematology/Oncology at ASH 2021 Annual Meeting
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 16 new data abstracts from across its hematology/oncology development program will...
Source: prnewswire.com
United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021
/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...
Source: prnewswire.com
United Therapeutics to Present New Data at CHEST Annual Meeting 2021
/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...
Informationandpatient Informationatwww Informationfor Remodulin Dewey Steadman Exchange Commission United Therapeutics Corporation Nasdaq Health Outcomes
Source: prnewswire.com
argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings
Argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings - read this article along with other careers information, tips and advice on BioSpace
United States Chafic Karam Michelle Greenblatt Gregoryw Fulton Demyelinating Polyneuropathy Jeffrey Guptill
Source: biospace.com
Urovant Sciences, Inc.: Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA (vibegron) 75 mg for Overactive Bladder at the 2021 Annual Meeting of the American Urological Association
Data from the dedicated, stand-alone, ambulatory blood pressure trial will be the focus of a podium presentation Efficacy in patients with 'dry' overactive bladder, based on a post-hoc analysis
Source: finanznachrichten.de